Meningioma pathophysiology

Jump to navigation Jump to search

Meningioma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Meningioma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Meningioma pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Meningioma pathophysiology

All Images
X-rays
Echo and Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Meningioma pathophysiology

CDC on Meningioma pathophysiology

Meningioma pathophysiology in the news

Blogs on Meningioma pathophysiology

Directions to Hospitals Treating Meningioma

Risk calculators and risk factors for Meningioma pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [2]

Overview

Pathogenesis

Meningioma arise from arachnoidal cells, most of which are near the vicinity of the venous sinuses, and this is the site of greatest prevalence for meningioma formation. They are most frequently attached to the dura over the superior parasagittal surface of frontal and parietal lobes, along the sphenoid ridge, in the olfactory grooves, the sylvian region, superior cerebellum along the falx cerebri, cerebellopontine angle, and the spinal cord. The tumor is usually gray, well-circumscribed, and takes on the form of space it occupies. They are usually dome-shaped, with the base lying on the dura.

Meningiomas are the most common benign tumors of the brain (95% of benign tumors), rare meningioma can be malignant. It arises from the meninges which surround the brain and spinal cord. A small meningioma causes no significant signs. With the development of the lump, frequent symptoms include changes in vision, for example seeing double or blurriness, headache, hearing loss memory loss, etc. A meningioma doesn't always require immediate treatment. Treatments include surgery, radiation and a combination of them.

Histologically, the cells are relatively uniform, with a tendency to encircle one another, forming whorls and psammoma bodies (laminated calcific concretions). They have a tendency to calcify and are highly vascularized.

Genetics

Gross Pathology

Microscopic Pathology

  • On microscopic histopathological analysis, whorled appearance, calcification, and psammoma bodies are characteristic findings of of meningioma.
  • The table below differentiates between the three main groups of multiple myeloma according to WHO histological classification:
Grade Histologic criteria Image

Benign (Grade I) meningioma

Less then 4 mit/10 HPF and no atypia

Grade 1 Meningioma

Atypical (Grade II) meningioma

Brain invasion, 4 or more mit/10 HPF, necrosis, increased cellularity, high nucleus:cytoplasm ratio, nucleoli, sheeting

Grade 2 menigioma.jpg

Anaplastic (Grade III) meningioma

20 or more mitoses/10 HPF, morphology similar to carcinoma or sarcoma

Grade 3 menigioma


  • Shown below is a series of microscopic images featuring specific findings seen in each subtype of meningioma:

References


Template:WikiDoc Sources